{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:16:21Z","timestamp":1783156581910,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004196","name":"Odense University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region of Southern Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010357","name":"Engineer K A Rohde and Wife Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.euros.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:56:54Z","timestamp":1779908214000},"page":"23-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET\/ceCT Versus Na[18F]F-PET\/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6456-2593","authenticated-orcid":false,"given":"Karen M.","family":"Buch-Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinbj\u00f8rn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie H.","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads H.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paw C.","family":"Holdgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten E.A.","family":"Zieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Asmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorun","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper T.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren S.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oke","family":"Gerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene G.","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.05.013_b0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00256-019-03230-z","article-title":"Comparison of PSMA-PET\/CT, choline-PET\/CT, NaF-PET\/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis","volume":"48","author":"Zhou","year":"2019","journal-title":"Skelet Radiol"},{"key":"10.1016\/j.euros.2026.05.013_b0010","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.05.013_b0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.eururo.2025.03.003","article-title":"A comprehensive systematic review and meta-analysis of the role of prostate-specific membrane antigen positron emission tomography for prostate cancer diagnosis and primary staging before definitive treatment","volume":"87","author":"Mazzone","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.013_b0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41391-024-00850-y","article-title":"A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET\/CT in the initial staging of prostate cancer","volume":"28","author":"Mari","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euros.2026.05.013_b0025","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2026.05.013_b0030","first-page":"218","article-title":"Diagnostic test accuracy study of 18F-sodium fluoride PET\/CT, 99mTc-labelled diphosphonate SPECT\/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer","volume":"7","author":"Fonager","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2026.05.013_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.125.270710","article-title":"Primary staging of intermediate- and high-risk prostate cancer using [18F]PSMA-1007 PET\/CT and [18F]NaF PET\/CT: a head-to-head comparison of diagnostic accuracy, staging, and patient management","volume":"67","author":"Buch-Olsen","year":"2026","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2026.05.013_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.013_b0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.013_b0050","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.05.013_b0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bco2.243","article-title":"A randomised trial of [18F]PSMA-1007-PET\/CT versus NaF-PET\/CT for staging primary prostate cancer: a trial protocol","volume":"4","author":"Buch-Olsen","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euros.2026.05.013_b0060","unstructured":"Kliniske retningslinier. Stadieinddeling af prostatacancer. https:\/\/www.dmcg.dk\/Kliniske-retningslinjer\/kliniske-retningslinjer-opdelt-paa-dmcg\/daproca\/stadieinddeling-af-prostatacancer\/. Accessed January 24, 2025."},{"key":"10.1016\/j.euros.2026.05.013_b0065","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.2022.21506","article-title":"Adjustment for baseline characteristics in randomized clinical trials","volume":"328","author":"Holmberg","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.05.013_b0070","series-title":"Survival analysis: a self-learning text","author":"Kleinbaum","year":"2012"},{"key":"10.1016\/j.euros.2026.05.013_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.120.246363","article-title":"Diagnostic accuracy of 18F-PSMA-1007 PET\/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence","volume":"62","author":"Sprute","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2026.05.013_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2967\/jnumed.117.197160","article-title":"The impact of 68Ga-PSMA PET\/CT on management intent in prostate cancer: results of an Australian prospective multicenter study","volume":"59","author":"Roach","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2026.05.013_b0085","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2967\/jnumed.124.268275","article-title":"18F-PSMA PET\/CT Versus 18F-NaF PET\/CT for staging and treating newly diagnosed high-risk prostate cancer: a prospective single-center study","volume":"66","author":"Madsen","year":"2025","journal-title":"J Nucl Med"},{"issue":"Suppl. 1","key":"10.1016\/j.euros.2026.05.013_b0090","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0022-510X(09)71300-0","article-title":"The Will Rogers phenomenon: the effect of different diagnostic criteria","volume":"287","author":"Pia Sormani","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euros.2026.05.013_b0095","unstructured":"Cancer Research UK. Prostate cancer statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer. Accessed August 28, 2025."}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:25:53Z","timestamp":1783153553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326005136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"alternative-id":["S2666168326005136"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.013","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET\/ceCT Versus Na[18F]F-PET\/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}